ANXA4 and urinary bladder carcinoma: Despite extensive research on CYTB, ANXA4, and SBP1 in bladder cancer tissue, direct studies on C1QC’s role in bladder cancer are limited, though its immune regulatory functions suggest it could influence tumor progression.